Quell Hype About New Quviviq for Insomnia

June 2022

You'll hear buzz about Rx Quviviq (daridorexant) for insomnia.

It's a me-too orexin antagonist...in the same family as Belsomra (suvorexant) and Dayvigo (lemborexant). All are C-IVs.

Quviviq will be touted to help patients fall asleep faster...stay asleep longer...and feel less tired during the day. Reps will also say it can be used nightly...with no max duration.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Aspirin Clear Up Confusion About Aspirin for CV Primary Prevention
Bites & Stings Be Ready for Questions About Insect and Tick Repellents
Insomnia Quell Hype About New Quviviq for Insomnia
Travel Medicine Share Strategies to Prevent Blood Clots When Traveling
Psychiatry Suggest a Practical Approach to Manage Agitation in Dementia
Med Safety Put PDE5 Inhibitor Risks in Perspective
Heart Failure Clarify New Heart Failure Terms and Management
Cancer Help Overcome Barriers to Opioid Use for Cancer Pain
IBS Watch for Ibsrela for Irritable Bowel Syndrome
Practice Optimize Care for Patients With Disabilities
Specialty Meds Understand Unique Considerations With Specialty Meds

Quell Hype About New Quviviq for Insomnia

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents